ArticleMolecular medicine reports2016

c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma.

Yan-Hui Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.